 |
|
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective
Diyang Xie, Jieyi Shi, Jian Zhou, Jia Fan, Qiang Gao
Clin Mol Hepatol. 2023;29(2):206-216. Published online 2022 Dec 22 DOI: https://doi.org/10.3350/cmh.2022.0402
|
|
Citations to this article as recorded by
 Triterpenes from Ganoderma lucidum inhibit hepatocellular carcinoma by regulating enhancer-associated lncRNA in vivo
Ruolin Zhao, Caiyun Zhang, Chenchen Tang, Xinxin Wu, Sheng Hu, Qingqiong Luo, Ning Jia, Lingzhi Fan, Yixing Wang, Wencheng Jiang, Qilong Chen
Journal of Ethnopharmacology.2025; 336: 118706. CrossRef Multi‐stage automatic and rapid ablation and needle trajectory planning method for CT‐guided percutaneous liver tumor ablation
Shengwei Li, Fanyu Zhou, Yumeng Zhang, Sheng Xu, Yufeng Wang, Lin Cheng, Zhixin Bie, Bin Li, Xiao‐Guang Li
Medical Physics.2025; 52(1): 113. CrossRef Xiaoai Jiedu recipe reduces cell survival and induces apoptosis in hepatocellular carcinoma by stimulating autophagy via the AKT/mTOR pathway
Yi Ji, Li Li, Wenting Li, Liu Li, Yanxia Ma, Qingfeng Li, Xi Chen, Wenyue Zhao, Hengzhou Zhu, Jiege Huo, Mianhua Wu
Journal of Ethnopharmacology.2025; 339: 119135. CrossRef AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis B
Hyunjae Shin, Moon Haeng Hur, Byeong Geun Song, Soo Young Park, Gi-Ae Kim, Gwanghyeon Choi, Joon Yeul Nam, Minseok Albert Kim, Youngsu Park, Yunmi Ko, Jeayeon Park, Han Ah Lee, Sung Won Chung, Na Ryung Choi, Min Kyung Park, Yun Bin Lee, Dong Hyun Sinn, Se
Journal of Hepatology.2025; 82(6): 1080. CrossRef Advancements in locoregional therapy for advanced hepatocellular carcinoma: Emerging perspectives on combined treatment strategies
Qi Liu, Renjie Zhang, Weixi Shen
European Journal of Surgical Oncology.2025; 51(2): 109502. CrossRef Efficiency and safety of HAIC combined with lenvatinib and tislelizumab for advanced hepatocellular carcinoma with high tumor burden: a multicenter propensity score matching analysis
Zhonghua Zhao, Xiongying Jiang, Shiping Wen, Yanzhang Hao
Frontiers in Pharmacology.2025;[Epub] CrossRef Juglone induces ferroptotic effect on hepatocellular carcinoma and pan-cancer via the FOSL1-HMOX1 axis
Chuyu Wang, Ying Zhao, Yingfei Peng, Wei Chen, Jie Zhu, Chenzheng Gu, Ran Huo, Lin Ding, Yu Liu, Te Liu, Chunyan Zhang, Wenjing Yang, Hao Wang, Wei Guo, Beili Wang
Phytomedicine.2025; 139: 156417. CrossRef PD(L)1 Inhibitors Plus Lenvatinib Vs Atezolizumab Plus Bevacizumab Combined With HAIC for Unresectable HCC: A Propensity Score Matching Study
Zhaoqian He, Hua Chen, Chen Liang, Xiang Tang, Lingmin Jiang, Feihu Xie, Qi Liu, Yun Zheng
ImmunoTargets and Therapy.2025; Volume 14: 51. CrossRef Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)?
Mario Romeo, Marcello Dallio, Carmine Napolitano, Claudio Basile, Fiammetta Di Nardo, Paolo Vaia, Patrizia Iodice, Alessandro Federico
Diagnostics.2025; 15(3): 252. CrossRef Epidemiological characteristics and precise prophylaxis and control of HBV-associated primary liver cancer
Yuqi Feng, Letian Fang, Guangwen Cao
Hepatoma Research.2025;[Epub] CrossRef The XIAP inhibitor AZD5582 improves the treatment effect of microwave ablation on hepatocellular carcinoma
Wenhui Wang, Fuyuan Wu, Zhe Wu, Mengfan Zhang, Qiang Lu
Frontiers in Immunology.2025;[Epub] CrossRef Urgent need for education on hepatocellular carcinoma surveillance among high-risk population in China
Lei Cai, Chao Li, Li-Yang Sun, Yong-Kang Diao, Ming-Da Wang, Tian Yang
Clinical and Molecular Hepatology.2025; 31(1): e39. CrossRef Single-cell transcriptomic analysis reveals efferocytosis signature predicting immunotherapy response in hepatocellular carcinoma
Longhu Li, Guangyao Li, Wangfeng Zhai
Digestive and Liver Disease.2025; 57(5): 1061. CrossRef Machine Learning Prognostic Model for Post-Radical Resection Hepatocellular Carcinoma in Hepatitis B Patients
Dalong Zhu, Alimu Tulahong, Abuduhaiwaier Abuduhelili, Chang Liu, Ayinuer Aierken, Yanze Lin, Tiemin Jiang, Renyong Lin, Yingmei Shao, Tuerganaili Aji
Journal of Hepatocellular Carcinoma.2025; Volume 12: 353. CrossRef BAIAP2L2 facilitates hepatocellular carcinoma progression and immune evasion of via targeting JAK1-mediated pathway and PD-L1 expression
Zhiyue Xie, Yanxia Wu, Nan Peng, Jing Wang, Hui Wang, Liang Zhao
Cancer Gene Therapy.2025; 32(4): 464. CrossRef Development and validation of an interpretable machine learning model for predicting the risk of hepatocellular carcinoma in patients with chronic hepatitis B: a case-control study
Linghong Wu, Zengjing Liu, Hongyuan Huang, Dongmei Pan, Cuiping Fu, Yao Lu, Min Zhou, Kaiyong Huang, TianRen Huang, Li Yang
BMC Gastroenterology.2025;[Epub] CrossRef Case Report: Successful immune checkpoint inhibitor rechallenge after sintilimab-induced Guillain-Barré syndrome
Lin Ye, Wan Rong Yue, Hao Shi, Jian Ren Li, Yu Ya Qun
Frontiers in Immunology.2025;[Epub] CrossRef Microalgae-based biodegradable embolic agent for the treatment of hepatocellular carcinoma through transarterial embolization
Kaiyue Wang, Danni Zhong, Lingxiao Yang, Cheng Zeng, Qitao Hu, Min Zhou, Zhe Tang
Journal of Nanobiotechnology.2025;[Epub] CrossRef Case Report: Posterior reversible encephalopathy syndrome after lenvatinib treatment for hepatocellular carcinoma
Minchun Chen, Jing Shen, Rongrong Jia, Mingze Chang, Jingyi Zhang, Jie Zheng, Runqing Xue, Lulu Guo, Kangkang Yan
Frontiers in Pharmacology.2025;[Epub] CrossRef AEBP1 inhibition reduces cell growth and PI3K/AKT pathway while less regulates cell mobility in hepatocellular carcinoma
Liyou Liu, Qingshan Cai, Dongyang Wu, Shudong Li, Dong Liu, Jianxing Zheng
World Journal of Surgical Oncology.2025;[Epub] CrossRef PD-1 inhibitors improve the efficacy of transcatheter arterial chemoembolization combined with apatinib in advanced hepatocellular carcinoma: a meta-analysis and trial sequential analysis
Jiahui Yu, Jinxin Yu, Yimiao Chen, Yuting Yang, Pengsheng Yi
BMC Cancer.2025;[Epub] CrossRef Preparation and Evaluation of Hepatoma-Targeting Glycyrrhetinic Acid Composite Micelles Loaded with Curcumin
Xueli Guo, Zhongyan Liu, Lina Wu, Pan Guo
Pharmaceuticals.2025; 18(4): 448. CrossRef BEND3 promotes hepatocellular carcinoma progression and metastasis by activating the PI3K/AKT/mTOR pathway and inducing epithelial-mesenchymal transition
Liu-Lin Yang, Xing Chen, Kai-Ting Huang, Shao-Tong Tang, Gui-Yan Ye, Ji-Long Wang
Clinics and Research in Hepatology and Gastroenterology.2025; 49(5): 102582. CrossRef Deletion of Tfap2a in hepatocytes and macrophages promotes the progression of hepatocellular carcinoma by regulating SREBP1/FASN/ACC pathway and anti-inflammatory effect of IL10
Zhiwei Li, Chun Zhang, Guixiang Huang, Zixin Zhang, Qinghao Wang, Xiran Liu, Yanling Qin, Hao Zhou, Anyi Hou, Jun He, Limin Li, Xiang Hu, Xiaofeng Ding
Cell Death & Disease.2025;[Epub] CrossRef Prognostic nutritional index predicts survival in intermediate and advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy combined with PD-(L)1 inhibitors and molecular targeted therapies
Hao-Huan Tang, Ming-Qing Zhang, Zi-Chen Zhang, Chen Fan, Shu-Shu Li, Wei Chen, Wei-Dong Wang
BMC Cancer.2025;[Epub] CrossRef METTL1-driven nucleotide metabolism reprograms the immune microenvironment in hepatocellular carcinoma: a multi-omics approach for prognostic biomarker discovery
Xie Weng, Yangyue Huang, Zhuoya Fu, Xingli Liu, Fuli Xie, Jiale Wang, Qiaohua Zhu, Dayong Zheng
Frontiers in Immunology.2025;[Epub] CrossRef Building a Predictive Model for the
Hemodynamic Effects of Regorafenib on
Portal Vein in Patients with Advanced
Hepatocellular Carcinoma Based on Machine Learning Algorithms
建阁 曾
Advances in Clinical Medicine.2025; 15(04): 3130. CrossRef The application progress of PAMAM dendrimer in cancer imaging and treatment
Cong-Ying Zhang, Kai Gu, Meng-Yi Chi, Xiao-Yan Gao, Ling Gao, Nan-Nan Zhang, Yu-Xi Liu, Tian-Zhu Li
Journal of Biomaterials Science, Polymer Edition.2025; : 1. CrossRef Donafenib and sintilimab combined with hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma: a prospective, single-arm phase II trial (DoHAICs study)
Wei Gao, Zhao-Long Pan, Xiao-Hui Zhao, Lu Yang, Jun-Bo Cao, Dong-Yang Li, Hai-Jing Zheng, Chen Liu, Guang-Tao Li, Xu Bao, Xiao-Meng Liu, Wei-Hao Zhang, Xiao-Lin Zhu, Bo-Han Xiao, Tian-Qiang Song, Qiang Li, Wei Lu, Wen-Ge Xing, Wei Zhang
eClinicalMedicine.2025; 83: 103217. CrossRef Efficacy and safety of neoadjuvant systemic therapy in resectable hepatocellular carcinoma: a Systematic Review and meta-analysis
Dongdong Wu, Ning Liu, Hao Dong, Kan Zhou, Lei Du, Ying Li, Yanjun Chao, Fuping Ma
Frontiers in Oncology.2025;[Epub] CrossRef Sex disparities in hepatocellular carcinoma immunotherapy: hormonal and genetic influences on treatment efficacy
Lei Song, Liyan Sun, Yuning Ren, Xiaodan Wang, Lei Xian
Frontiers in Immunology.2025;[Epub] CrossRef Bibliometric analysis of hepatocellular carcinoma and tyrosine kinase inhibitors
Wurihan Wu, Hejun Mao, Jian Song, Fan Yang
Medicine.2025; 104(20): e42015. CrossRef Massive extrapancreatic solid pseudopapillary neoplasm misdiagnosed as hepatic tumor: a case report and literature review
Jixu Guo, Qingjuan Zhao, Liting Qin, Shengjie Xie, Shiliu Lu, Baibei Li, Meilin He, Linhong Xie, Shuiping Yu
Frontiers in Oncology.2024;[Epub] CrossRef A novel nomogram to predict the overall survival of early-stage hepatocellular carcinoma patients following ablation therapy
Honghai Zhang, Shugui Sheng, Wenying Qiao, Ming Han, Ronghua Jin
Frontiers in Oncology.2024;[Epub] CrossRef Novel insights into small open reading frame-encoded micropeptides in hepatocellular carcinoma: A potential breakthrough
Qiangnu Zhang, Liping Liu
Cancer Letters.2024; 587: 216691. CrossRef Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
Josep M. Llovet, Roser Pinyol, Mark Yarchoan, Amit G. Singal, Thomas U. Marron, Myron Schwartz, Eli Pikarsky, Masatoshi Kudo, Richard S. Finn
Nature Reviews Clinical Oncology.2024; 21(4): 294. CrossRef Nomogram for Predicting Postoperative Pulmonary Metastasis in Hepatocellular Carcinoma Based on Inflammatory Markers
Huanjie Zhou, Haiping Zheng, Ying Wang, Ming Lao, Hong Shu, Meifang Huang, Chao Ou
Cancer Control.2024;[Epub] CrossRef
KDM4A-AS1 Promotes Cell Proliferation, Migration, and Invasion via the miR-4306/STX6 Axis in Hepatocellular Carcinoma
Wei Cao, Yuhan Ren, Ying Liu, Guoshu Cao, Zhen Chen, Fan Wang
Critical Reviews in Eukaryotic Gene Expression.2024; 34(4): 55. CrossRef Development of Shark Single Domain Antibodies Specific for Human α-Fetoprotein and the Multimerization Strategy in Serum Detection
Zheming Wang, Xiaoxia Xie, Zhenyun He, Zhichang Sun, Yongli Zhang, Fujing Mao, Hua Pei, Sihang Zhang, Bruce D. Hammock, Xing Liu
Analytical Chemistry.2024; 96(10): 4242. CrossRef The significance of m6A RNA methylation regulators in diagnosis and subtype classification of HBV-related hepatocellular carcinoma
Qijuan Zang, Yalin Ju, Siyi Liu, Shaobo Wu, Chengbin Zhu, Liangru Liu, Weicheng Xu, Yingli He
Human Cell.2024; 37(3): 752. CrossRef Pre-operative enhanced magnetic resonance imaging combined with clinical features predict early recurrence of hepatocellular carcinoma after radical resection
Jian-Ping Chen, Ri-Hui Yang, Tian-Hui Zhang, Li-An Liao, Yu-Ting Guan, Hai-Yang Dai
World Journal of Gastrointestinal Oncology.2024; 16(4): 1192. CrossRef Interim analysis of the PARADISE study: Benefits of add-on peginterferon-α in NA-treated patients with CHB
Shaowen Jiang, Simin Guo, Yan Huang, Jie Xu, Yi Li, Yilan Zeng, Yuan Guo, Lijuan Ouyang, Chuanwu Zhu, Weifeng Zhao, Qin Zhang, Qing Guo, Haiguang Xin, Qing Xie
Antiviral Research.2024; 226: 105892. CrossRef Hepatocellular Carcinoma: Current Drug Therapeutic Status, Advances and Challenges
Shunzhen Zheng, Siew Wee Chan, Fei Liu, Jun Liu, Pierce Kah Hoe Chow, Han Chong Toh, Wanjin Hong
Cancers.2024; 16(8): 1582. CrossRef Clinical efficacy of lenvatinib, trans-arterial chemoembolization, and PD-1/L1 inhibitors in advanced hepatocellular carcinoma: a systematic review and network meta-analysis
YiFeng Liang, LiMing Gan, DeJin Zeng, LangHua Lin, ZheKun Xiong, FangLian Liao, ALing Wang
Clinical and Translational Oncology.2024; 26(10): 2652. CrossRef Higher objective responses by hepatic arterial infusion chemotherapy following atezolizumab and bevacizumab failure than when used as initial therapy in hepatocellular carcinoma: a retrospective study
Jae-Sung Yoo, Ji Hoon Kim, Hee Sun Cho, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Suho Kim, Jung Suk Oh, Ho Jong Chun, Pil Soo Sung
Abdominal Radiology.2024; 49(9): 3127. CrossRef Conversion therapy for advanced hepatocellular carcinoma in the era of precision medicine: Current status, challenges and opportunities
Ming‐Da Wang, Xue‐Jun Xu, Ke‐Chun Wang, Yong‐Kang Diao, Jia‐Hao Xu, Li‐Hui Gu, Lan‐Qing Yao, Chao Li, Guo‐Yue Lv, Tian Yang
Cancer Science.2024; 115(7): 2159. CrossRef Dual-molecular targeting nanomedicine upregulates synergistic therapeutic efficacy in preclinical hepatoma models
Qilong Wang, Xiwei Sun, Xizhu Fang, Zhongying Wang, Haodong Wang, Siqiao Sun, Shuai Wang, Tingting Li, Ping Zhang, Zhihua Cheng
Acta Biomaterialia.2024; 183: 306. CrossRef Research Progress on the Role of Epigenetic Methylation Modification in Hepatocellular Carcinoma
Jing Wang, Wenyue Gao, Hongbo Yu, Yuting Xu, Changchuan Bai, Qingwei Cong, Ying Zhu
Journal of Hepatocellular Carcinoma.2024; Volume 11: 1143. CrossRef Comprehensive Bioinformatics Analysis and Machine Learning of TTK as a Transhepatic Arterial Chemoembolization Resistance Target in Hepatocellular Carcinoma
Yangyang Xiao, Youwen Hu
Molecular Biotechnology.2024;[Epub] CrossRef TRIM33 enhances the ubiquitination of TFRC to enhance the susceptibility of liver cancer cells to ferroptosis
Wenjing Ji, Weibin Zhang, Xin Zhang, Yue Ke
Cellular Signalling.2024; 121: 111268. CrossRef Breaking Down the Arsenal: Recent Progress in the Nanotherapeutic Strategies for Hepatocellular Carcinoma Treatment
Sumit Roy, Vancha Harish, Sharfuddin Mohd, Sachin Kumar Singh
Advanced Therapeutics.2024;[Epub] CrossRef Effectiveness and safety of vascular intervention plus lenvatinib versus vascular intervention alone for hepatocellular carcinoma patients with portal vein tumor thrombus: a retrospective comparative study
Saikang Tang, Yingming Gao, Xue Yan, Weihua Zhi, Yue Han
Frontiers in Oncology.2024;[Epub] CrossRef Efficacy and safety of apatinib plus immune checkpoint inhibitors and transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma
Jianfei Wu, Xuefeng Bai, Guodong Yu, Quan Zhang, Xixi Tian, Yuan Wang
Journal of Cancer Research and Clinical Oncology.2024;[Epub] CrossRef The potential of lenvatinib in breast cancer therapy
Yuefeng Shang, Tong Liu, Wenjing Wang
Medical Oncology.2024;[Epub] CrossRef Evaluating the impact of treatment sequencing on outcomes in hepatocellular carcinoma: a comparative analysis of TACE and systemic therapies
XingRong Zheng, Xin Song, BoXiang Zhang, XiYao Chen, YeQiong Zhang, QiuMin Luo, ZhiPeng Li, ZheXuan Deng, RuiXuan Xu, Liang Peng, Chan Xie
Clinical and Experimental Medicine.2024;[Epub] CrossRef Development and validation of survival prediction models for patients with hepatocellular carcinoma treated with transcatheter arterial chemoembolization plus tyrosine kinase inhibitors
Kun Huang, Haikuan Liu, Yanqin Wu, Wenzhe Fan, Yue Zhao, Miao Xue, Yiyang Tang, Shi-Ting Feng, Jiaping Li
La radiologia medica.2024; 129(11): 1597. CrossRef TAF15 inhibits p53 nucleus translocation and promotes HCC cell 5-FU resistance via post-transcriptional regulation of UBE2N
Jiayan Fang, Mengqi Zou, Mei Yang, Yejia Cui, Rong Pu, Yufeng Yang
Journal of Physiology and Biochemistry.2024; 80(4): 919. CrossRef Low miR-936-mediated upregulation of Pim-3 drives sorafenib resistance in liver cancer through ferroptosis inhibition by activating the ANKRD18A/Src/NRF2 pathway
Xiao Li, Mengna Cui, Long Xu, Qie Guo
Frontiers in Oncology.2024;[Epub] CrossRef Metabolic dysfunction-associated fatty liver disease related hepatocellular carcinoma in China: An increasing problem: Letter to the edior on “Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A sy
Xiangyu Wu, Wenjing Ni, Qianqian Chen, Junping Shi, Jie Li
Clinical and Molecular Hepatology.2024; 30(4): 965. CrossRef Multicenter Study on Transarterial Chemoembolization Combined with Radiofrequency Ablation for Early-Stage Hepatocellular Carcinoma: Primary versus Recurrent HCC
Yu-Tang Chen, Bo-Wen-Tao Chen, Jun-Ming Xu, Xiao-Cui You, Yi Tang, Shao-Jie Wu, Zhu-Ting Fang
Journal of Hepatocellular Carcinoma.2024; Volume 11: 2441. CrossRef APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024
George Lau, Shuntaro Obi, Jian Zhou, Ryosuke Tateishi, Shukui Qin, Haitao Zhao, Motoyuki Otsuka, Sadahisa Ogasawara, Jacob George, Pierce K. H. Chow, Jianqiang Cai, Shuichiro Shiina, Naoya Kato, Osamu Yokosuka, Kyoko Oura, Thomas Yau, Stephen L. Chan, Min
Hepatology International.2024; 18(6): 1661. CrossRef Camrelizumab plus rivoceranib compared sorafenib as first-line therapeutic options for advanced hepatocellular carcinoma in China: a cost-effectiveness analysis
Hongfu Cai, Jingwen Lin, Huide Zhu, Zhiwei Zheng
BMJ Open.2024; 14(12): e079603. CrossRef Bufonis venenum extract loaded novel cholesterol-free liposome for the treatment of hepatocellular carcinoma
Siqi Yang, Jinshuai Lan, Zhe Li, Ming Li, Ya Wu, Liyan Sun, Tong Zhang, Yue Ding
Frontiers in Pharmacology.2024;[Epub] CrossRef Cost-effectiveness of camrelizumab plus rivoceranib for advanced hepatocellular carcinoma in the context of regional disparities in China
Zhonghua Zhao, Xiongying Jiang, Shiping Wen, Yanzhang Hao
Frontiers in Oncology.2024;[Epub] CrossRef Bavachin stimulates ferroptosis and reduces malignant phenotype progression of hepatocellular carcinoma cells by inducing lipid peroxidation by modulation of the Nrf2/HO-1 signaling pathway
Haoyu Li
American Journal of Translational Research.2024; 16(11): 6925. CrossRef Management of hepatocellular carcinoma in China: Seeking common grounds while reserving differences
Tian Yang, Ming-Da Wang, Xin-Fei Xu, Chao Li, Han Wu, Feng Shen
Clinical and Molecular Hepatology.2023; 29(2): 342. CrossRef The clinical management of hepatocellular carcinoma in China: Progress and challenges
Shan Shan, Jidong Jia
Clinical and Molecular Hepatology.2023; 29(2): 339. CrossRef A bibliometric study on the utilization of lenvatinib in hepatocellular carcinoma (2014–2022)
Cong-Cong Wang, Cai-Yan Yu, Jing Zhang, Rui Wang, Xiang-Shuo Kong
Frontiers in Pharmacology.2023;[Epub] CrossRef PEG-grafted arsenic trioxide-loaded mesoporous silica nanoparticles endowed with pH-triggered delivery for liver cancer therapy
Liangdi Jiang, Xuerui Wang, Faisal Raza, Hongyu Zhong, Jing Su, Wei-En Yuan, Mingfeng Qiu
Biomaterials Science.2023; 11(15): 5301. CrossRef From clinical variables to multiomics analysis: a margin morphology-based gross classification system for hepatocellular carcinoma stratification
Zhongqi Fan, Meishan Jin, Lei Zhang, Nanya Wang, Mingyue Li, Chuanlei Wang, Feng Wei, Ping Zhang, Xiaohong Du, Xiaodong Sun, Wei Qiu, Meng Wang, Hongbin Wang, Xiaoju Shi, Junfeng Ye, Chao Jiang, Jianpeng Zhou, Wengang Chai, Jun Qi, Ting Li, Ruoyan Zhang,
Gut.2023; 72(11): 2149. CrossRef Heterogeneity characterization of hepatocellular carcinoma based on the sensitivity to 5-fluorouracil and development of a prognostic regression model
Xinyu Gu, Shuang Li, Xiao Ma, Di Huang, Penghui Li
Frontiers in Pharmacology.2023;[Epub] CrossRef Tips for Preparing and Practicing Thermal Ablation Therapy of Hepatocellular Carcinoma
Yasunori Minami, Tomoko Aoki, Satoru Hagiwara, Masatoshi Kudo
Cancers.2023; 15(19): 4763. CrossRef A novel signature of the ligand and receptor genes associated with disulfidoptosis for prediction of prognosis, immunologic therapy responses in hepatocellular carcinoma
Chong Fu, Chang Cheng, Yanping Zhang
Heliyon.2023; 9(9): e19502. CrossRef Effect of intermittent Pringle maneuver on perioperative outcomes and long-term survival following liver resection in patients with hepatocellular carcinoma: a meta-analysis and systemic review
Lingbo Hu, Aidong Wang, Yingli Qiao, Xiandan Huang
World Journal of Surgical Oncology.2023;[Epub] CrossRef
|